In the past, many efforts with less effectiveness have been made to overcome obstacles to insulin absorption via the gastrointestinal mucosa1 . The low bioavailability of insulin administration via oral route is mainly due to enzymatic degradation in the gastrointestinal tract and those are absorbed, are exposed to the first-pass metabolism. Hence, therapeutical usefulness of this macromolecule has been achieved by multiple injections which encountered with low patient compliance